A Phase 1 Study of the Safety of AAV8-LSPhGAA (ACTUS-101) in Late-onset Pompe Disease (LOPD)- Cohort II
Clinical Trial Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Asklepios BioPharmaceutical, Inc.
Start Date
July 8, 2019
End Date
May 1, 2026
Administered By
Pediatrics, Medical Genetics
Awarded By
Asklepios BioPharmaceutical, Inc.
Start Date
July 8, 2019
End Date
May 1, 2026